Ardelyx reported $249.15M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Amgen USD 541M 0 Sep/2026
Ardelyx USD 249.15M 2.17M Jun/2026
aTyr Pharma USD 63.76M 765K Jun/2026
Corcept Therapeutics USD 109.36M 1.44M Sep/2026
Curis USD 2M 10.93M Mar/2026
Sanofi EUR 1.2B 2.15M Jun/2026
TG Therapeutics USD 151.16M 1.92M Sep/2026
United Therapeutics USD 42.38M 295K Sep/2026